- Home
- MYSZ vs NCNA Comparison
MYSZ vs NCNA Comparison
Compare MYSZ & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- NCNA
- Stock Information
- Founded
- MYSZ 1999
- NCNA 1997
- Country
- MYSZ Israel
- NCNA United Kingdom
- Employees
- MYSZ N/A
- NCNA N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- MYSZ Technology
- NCNA Health Care
- Exchange
- MYSZ Nasdaq
- NCNA Nasdaq
- Market Cap
- MYSZ 3.8M
- NCNA 4.5M
- IPO Year
- MYSZ N/A
- NCNA 2017
- Fundamental
- Price
- MYSZ $1.40
- NCNA $0.06
- Analyst Decision
- MYSZ Strong Buy
- NCNA Buy
- Analyst Count
- MYSZ 1
- NCNA 2
- Target Price
- MYSZ $3.00
- NCNA $25.00
- AVG Volume (30 Days)
- MYSZ 71.0K
- NCNA 318.7M
- Earning Date
- MYSZ 08-11-2025
- NCNA 08-14-2025
- Dividend Yield
- MYSZ N/A
- NCNA N/A
- EPS Growth
- MYSZ N/A
- NCNA N/A
- EPS
- MYSZ N/A
- NCNA N/A
- Revenue
- MYSZ $6,752,000.00
- NCNA N/A
- Revenue This Year
- MYSZ $29.71
- NCNA N/A
- Revenue Next Year
- MYSZ N/A
- NCNA N/A
- P/E Ratio
- MYSZ N/A
- NCNA N/A
- Revenue Growth
- MYSZ N/A
- NCNA N/A
- 52 Week Low
- MYSZ $1.01
- NCNA $0.03
- 52 Week High
- MYSZ $9.40
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- MYSZ 58.78
- NCNA 39.77
- Support Level
- MYSZ $1.20
- NCNA $0.05
- Resistance Level
- MYSZ $1.21
- NCNA $0.06
- Average True Range (ATR)
- MYSZ 0.06
- NCNA 0.01
- MACD
- MYSZ 0.02
- NCNA 0.00
- Stochastic Oscillator
- MYSZ 82.14
- NCNA 12.16
About MYSZ My Size Inc.
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.